Suven Life Sciences spurts on securing patents for three products

30 Dec 2014 Evaluate

Suven Life Sciences is currently trading at Rs. 217.00, up by 9.45 points or 4.55 % from its previous closing of Rs. 207.55 on the BSE.

The scrip opened at Rs. 208.05 and has touched a high and low of Rs. 219.50 and Rs. 206.50 respectively. So far 86146 shares were traded on the counter.

The BSE group 'B' stock of face value Re. 1 has touched a 52 week high of Rs. 236.50 on 03-Nov-2014 and a 52 week low of Rs. 67.50 on 27-Jan-2014.

Last one week high and low of the scrip stood at Rs. 217.00 and Rs. 206.35 respectively. The current market cap of the company is Rs. 2662.11 crore.

The promoters holding in the company stood at 64.76 % while Institutions and Non-Institutions held 1.97 % and 33.27 % respectively.

Suven Life Sciences has received the grant of one product patent from Eurasia, one product patent from Japan and one product patent from Mexico corresponding to the New Chemical Entities (NCEs) for the treatment of disorders associated with Neurodegenerative diseases and these Patents are valid through 2029.

The granted claims of the patents include the class of selective 5-HT compounds discovered by Suven and are being developed as therapeutic agents and are useful in the treatment of cognitive impairment associated with neurodegenerative disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Parkinson and Schizophrenia.

With these new patents, Suven has a total of thirteen granted patents from Eurasia, twelve granted patents from Japan and seventeen product patents from Mexico. These granted patents are exclusive intellectual property of Suven and are achieved through the internal discovery research efforts. Products out of these inventions may be out-licensed at various phases of clinical development like at Phase-I or Phase-II.

Suven Life Sciences Share Price

166.05 -1.75 (-1.04%)
26-Dec-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1719.20
Dr. Reddys Lab 1269.05
Cipla 1505.05
Zydus Lifesciences 911.50
Lupin 2112.95
View more..
Register Now to get our Free Newsletter & much more!

© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.

×